Company Filing History:
Years Active: 2022-2024
Title: Innovations of Timothy Ryan Mooney
Introduction
Timothy Ryan Mooney is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) technologies. With a total of two patents to his name, Mooney's work focuses on innovative methods for treating diseases associated with xanthine dehydrogenase (XDH).
Latest Patents
Mooney's latest patents include compositions and methods related to xanthine dehydrogenase (XDH) iRNA agents. These inventions involve double-stranded RNAi agents that target the XDH gene. The methods outlined in these patents aim to inhibit the expression of the XDH gene, providing potential treatments for subjects suffering from XDH-associated diseases.
Career Highlights
Timothy Ryan Mooney is currently employed at Alnylam Pharmaceuticals, Inc., a leading company in the field of RNAi therapeutics. His work at Alnylam has positioned him at the forefront of innovative research and development in biotechnology. Mooney's expertise and contributions have been instrumental in advancing the understanding and application of RNAi technologies.
Collaborations
Some of Mooney's notable coworkers include Kevin Fitzgerald and Gregory Hinkle. Their collaborative efforts contribute to the dynamic research environment at Alnylam Pharmaceuticals, fostering innovation and the development of groundbreaking therapies.
Conclusion
Timothy Ryan Mooney's work exemplifies the spirit of innovation in biotechnology. His patents and contributions to RNAi technology hold promise for the treatment of diseases linked to xanthine dehydrogenase. Through his career at Alnylam Pharmaceuticals, Mooney continues to push the boundaries of scientific research and development.